Transparency Market Research
Lung Cancer Treatment Market Revenue to Cross USD 102 billion by 2031, Expanding at a CAGR of 9.8% Says, Transparency Market Research Inc.
August 21, 2023 10:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global lung cancer treatment market is projected to flourish at a CAGR of 9.8% from...
Transparency Market Research
Acute Lymphoblastic Leukemia Market Size to Surpass USD 4.5 billion by 2031, globally, expanding at a CAGR of 7.6%: TMR Report
August 04, 2023 10:00 ET | Transparency Market Research
Wilmington, Delaware, United States, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The global acute lymphoblastic leukemia market is projected to flourish at a CAGR of 7.6% from 2022 to 2031. As per the report...
22157.jpg
United Kingdom Private Acute Healthcare Market Report 2023: A Vital Resource for Anyone in this Highly Competitive Sector
August 02, 2023 07:13 ET | Research and Markets
Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Private Acute Healthcare UK Market Report (9th Edition)" report has been added to ResearchAndMarkets.com's offering. The Private Acute Healthcare UK...
Global Thyroid Cancer Drugs Market
Global Thyroid Cancer Drugs Market to Reach $1.29 Billion by 2027: Targeted Therapies Transforming Thyroid Cancer Treatment
July 31, 2023 05:33 ET | Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market Report 2023" has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive guide to...
Transparency Market Research
CINV Existing and Pipeline Drugs Market to reach US$ 3.2 billion in 2031, expanding at a CAGR of 5.8%: TMR Report
July 18, 2023 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) -- In 2021, the global CINV existing and pipeline drugs market was estimated to be worth US$ 1.9 billion. It is expected to...
Global Urothelial Cancer Drugs Market
Global Web Analytics Market to Reach $13.92 Billion by 2027, Driven by Growing Demand for Online Shopping and Technological Advancements
July 14, 2023 04:53 ET | Research and Markets
Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global web analytics market is...
MicrosoftTeams-image (5).png
Prostate Cancer Therapeutics Market Projected to Grow at 6.9% CAGR, Reaching USD 21.7 Billion by 2031: TMR Study
July 10, 2023 05:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global prostate cancer therapeutics market is projected to expand at a CAGR of 6.9% from 2022 to 2031 to reach US$ 21.7 Bn...
MicrosoftTeams-image (5).png
DNA Repair Drugs Market to Grow at 6.5% CAGR, Touching US$ 10.4 Bn by 2031: TMR Study
July 05, 2023 07:15 ET | Transparency Market Research
Wilmington, Delaware, United States, July 05, 2023 (GLOBE NEWSWIRE) -- The global DNA repair drugs market was valued at US$ 5.9 Bn in 2022 and is projected to reach US$ 10.4 Bn by 2031 with CAGR of...
22157.jpg
Worldwide Oncology Partnering Deals Collection 2016-2023: Access to Headline, Upfront, Milestone and Royalty Data
June 28, 2023 04:43 ET | Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.The is report...
BTG Pharmaceuticals
BTG Pharmaceuticals Statement on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommendation for Use of Glucarpidase (Voraxaze®) and MTXPK.org
June 22, 2023 08:28 ET | BTG Specialty Pharmaceuticals
West Conshohocken, PA, June 22, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, highlights the recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for Acute...